Associate Director, HEOR, Hematology, Europe and New Markets

--- base: / meta-keywords: meta-viewport: width=device-width, initial-scale=1.0 --- Associate Director, HEOR, Hematology, Europe and New Markets ============================================================ Take a key role in shaping HEOR evidence strategy across a global hematology portfolio, supporting European HTA and JCA readiness across Europe and New Markets. Associate Director, HEOR, Hematology, Europe and New Markets ============================================================ ### Job description: * Support the development and delivery of HEOR strategies and evidence\-generation activities across hematology assets in Europe and New Markets. * Partner with Market Access, Medical Affairs, Clinical Development, Biostatistics and Global teams to identify evidence gaps and prioritize HEOR activities based on regional and country needs. * Develop and execute evidence\-generation projects, including comparative effectiveness research, real\-world evidence and health economic analyses. * Contribute to European HTA and EU Joint Clinical Assessment (JCA) evidence strategy and readiness. * Support JCA PICO strategy and planning, including assessment of relevant populations, subgroups, comparators and outcomes, identification of evidence gaps and evaluation of potential evidence\-generation approaches. * Lead or support comparative evidence generation for JCA and other HTA requirements. * Develop and critically review study protocols, analysis plans, reports, publications and other HEOR deliverables, ensuring scientific and methodological quality. * Evaluate clinical trial, external and real\-world data together with internal experts and external partners to determine the most appropriate approaches for addressing evidence gaps. * Manage external HEOR vendors and projects, including scope definition, methodological review, timelines, deliverables and quality control. * Support the interpretation and communication of HEOR evidence, including assumptions, uncertainty, limitations and implications for HTA and evidence strategy. ### About the customer: Our client is a global, science\-led biopharmaceutical company focused on oncology, with a strong international footprint and a commitment to accelerating the development of and access to innovative cancer medicines. With hematology as a core area of research and development, the organization combines global capabilities with a fast\-moving, collaborative culture and a strong focus on generating meaningful impact for patients. ### Requirements: * A Master’s degree or PhD in Health Economics, Outcomes Research, Epidemiology, Public Health, Statistics or a related discipline. * At least **5 years of relevant experience** in HEOR, HTA, real\-world evidence or comparative effectiveness research, ideally gained within the pharmaceutical/biotech industry or consulting. * A strong understanding of **European HTA and evidence requirements**; knowledge of or experience with the **EU HTA Regulation and Joint Clinical Assessment (JCA)** is a strong advantage. * Experience with comparative effectiveness methodologies such as **ITC/NMA** and, ideally, population\-adjusted approaches including **MAIC/STC**. * Hands\-on experience designing, managing and critically reviewing HEOR studies and collaborating with external research vendors. * Experience or knowledge within **hematology and/or oncology** would be an advantage. * Strong analytical and critical\-thinking skills, with the ability to translate evidence gaps into actionable research activities. * The ability to work effectively across functions and geographies while managing multiple projects and changing priorities. * Excellent written and verbal communication skills in English. * A proactive, highly organized and independent working style suited to a dynamic, fast\-paced environment. ![Swisslinx AG]() * Swisslinx AG Löwenstrasse 29 8001 Zürich * [](<>) jid7e7e405jm jit0938jm jiy26jm